Share on StockTwits

Analysts at Citigroup Inc. started coverage on shares of Medidata Solutions (NASDAQ:MDSO) in a research report issued to clients and investors on Tuesday, reports. The firm set a “buy” rating on the stock.

In other Medidata Solutions news, President Vries Glen Michael De sold 20,000 shares of Medidata Solutions stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $54.40, for a total value of $1,088,000.00. Following the sale, the president now directly owns 1,156,970 shares of the company’s stock, valued at approximately $62,939,168. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Other equities research analysts have also recently issued reports about the stock. Analysts at TheStreet downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Monday, February 10th. Separately, analysts at Zacks downgraded shares of Medidata Solutions from an “outperform” rating to a “neutral” rating in a research note on Thursday, February 6th. They now have a $68.40 price target on the stock. Finally, analysts at Zacks upgraded shares of Medidata Solutions from a “neutral” rating to an “outperform” rating in a research note on Wednesday, January 8th. They now have a $62.40 price target on the stock. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $109.30.

Shares of Medidata Solutions (NASDAQ:MDSO) opened at 58.39 on Tuesday. Medidata Solutions has a 52-week low of $23.60 and a 52-week high of $66.01. The stock’s 50-day moving average is $59.67 and its 200-day moving average is $53.34. The company has a market cap of $3.018 billion and a P/E ratio of 189.23.

Medidata Solutions (NASDAQ:MDSO) last released its earnings data on Thursday, February 6th. The company reported $0.23 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.17 by $0.06. The company had revenue of $74.60 million for the quarter, compared to the consensus estimate of $73.97 million. During the same quarter in the prior year, the company posted $0.25 earnings per share. The company’s quarterly revenue was up 27.3% on a year-over-year basis. Analysts expect that Medidata Solutions will post $0.78 EPS for the current fiscal year.

Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.